🟢 80/100

This product is generally safe

  • Magnesium Oxide: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
  • Zinc Sulfate: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)
  • 100% of ingredients have research evidence
D Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Magnesium Oxide: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
⚠️ Zinc Sulfate: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)

Label Data

2 Tablet(s) Serving Size
50 Servings
Other Combinations Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

1000 mg (123.4% DV)
✅ Within RDA (1.0× RDA of 1000 mg) 📚 436 studies (Tier A: 25, B: 228)
RDA 1000mg This product: 1000mg UL 2500mg
500 mg (125% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 350 mg) 📚 4 studies (Tier A: 0, B: 3)
RDA 420mg This product: 500mg UL 350mg
200 IU (50% DV)
✅ Within RDA (0.3× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.005mg UL 0.1mg
50 mg (334% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 40 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 50mg UL 40mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Magnesium Stearate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Menopause Sugar Free

Product Information

📋 Directions for Use

Suggested use: Adults (2) two to (6) six tablets daily with meals or as directed.

⚠️ Warnings & Precautions

Keep out of reach of children

🧪 Formulation Notes

We have also added Vitamin D to ensure a proper level of absorption of calcium.

It is particularly recommended for people suffering osteoporosis, mainly women during menopause.

This product does not contain sugar, starch, salt, artificial colors, flavors or preservatives.

Additional Information

These three minerals have been combined for their synergistic effect when taken together.

Made in the U.S.A.

To ensure a proper level of absorption

Osteo Forte

Product Details

UPC / SKU 7 89939 10031 8
DSLD Entry Date 2015-08-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 49755
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →